The emerging approach of this peptide represents a exciting development in the management of the condition. Distinct from existing medications, tirzepatide affects two pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide471928.bligblogging.com/42741113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment